(Q39833078)

15 September 2017

In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy (English)

1 reference

15 September 2017

McIntyre KA

1

1 reference

PMCID

176068

15 September 2017

Galgiani JN

series ordinal

2

1 reference

PMCID

176068

15 September 2017

language of work or name

English

0 references

publication date

1 July 1989

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

33

1 reference

15 September 2017

1095-1100

1 reference

15 September 2017

7

1 reference

Ornithyl amphotericin methyl ester treatment of experimental candidiasis in rats

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

In vitro antifungal activity of clotrimazole (Bay b 5097)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Pharmacological Studies with 5-Fluorocytosine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Effect of buffers on testing of Candida species susceptibility to flucytosine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Azole antifungal agents: emphasis on new triazoles

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Turbidimetric Studies of Growth Inhibition of Yeasts with Three Drugs: Inquiry into Inoculum-Dependent Susceptibility Testing, Time of Onset of Drug Effect, and Implications for Current and Newer Methods

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Susceptibility of Three Groups of Staphylococcus aureus to Newer Antimicrobial Agents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Antifungal agents: recent developments

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Factors Influencing the Susceptibility of Candida albicans to the Polyenoic Antibiotics Nystatin and Amphotericin B

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

In Vitro Studies of 5-Fluorocytosine Resistance in Candida albicans and Torulopsis glabrata

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Effects of pH on the Activity of Ketoconazole Against Candida albicans

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Increased arabinitol levels in experimental candidiasis in rats: arabinitol appearance rates, arabinitol/creatinine ratios, and severity of infection

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176068

Correlation of in Vitro Susceptibility Test Results with in Vivo Response: Flucytosine Therapy in a Systemic Candidiasis Model

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2551215

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Obfuscation of the Activity of Antifungal Antimicrobics by Culture Media

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2551215

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.33.7.1095

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

PMCID

176068